via Nextgov
Drugs used for curing hepatitis C might also help against Covid-19 / World Health Organization publishes paper presented by researchers from Mainz University
“This computer simulation method is known as molecular docking and it has been recognized and used for years. It is much faster and less expensive than lab experiments,” said Professor Thomas Efferth of the JGU Institute of Pharmacy and Biomedical Sciences, lead author of the study. “As far as we know, we were the first to have used molecular docking with SARS-CoV-2. And it is fantastic news that we have found a number of approved hepatitis C drugs as promising candidates for treatment.”
Using the MOGON II supercomputer, the researchers made more than 30 billion single calculations within two months and found that compounds from the four hepatitis C drugs simeprevir, paritaprevir, grazoprevir, and velpatasvir have a high affinity to bind SARS-CoV-2 very strongly and may therefore be able to prevent infection. “This is also supported by the fact that both SARS-CoV-2 and the hepatitis C virus are a virus of the same type, a so-called single-stranded RNA virus,” explained Efferth.
According to the researchers, a natural substance from the Japanese honeysuckle (Lonicera japonica), which has been used in Asia against various other diseases for some time now, might be another strong candidate against SARS-CoV-2. “Our research results now need to be checked in laboratory experiments and clinical studies,” said Efferth and added that molecular docking had already been used successfully in the search for active substances against the coronaviruses MERS-CoV and SARS-CoV.
The Latest Updates from Bing News & Google News
Go deeper with Bing News on:
COVID-19 drugs
- Bird flu outbreak in cows: Lessons learned from COVID-19 failures
Scientists are calling for public health agencies to pay attention to key issues from the COVID-19 pandemic as they mitigate the outbreak of bird flu.
- Can Neosporin Protect You From Getting COVID-19?
A small study recently published in PNAS presents a similar, if lower-tech, idea. Coating the inside of the nose with the over-the-counter antibiotic ointment Neosporin seems to trigger an immune ...
- Study: Antibiotic use in moderate COVID-19 linked to clinical deterioration
Antibiotic treatment of adults hospitalized with moderate COVID-19 is associated with clinical deterioration, despite the drugs being given to over 40% of patients, according to new research being ...
- Study: Antibiotic use in patients hospitalized with COVID-19 appears to have no beneficial effect on clinical outcomes
Antibiotic treatment of adults hospitalized with moderate COVID-19 is associated with clinical deterioration, despite the drugs being given to over 40% of patients, according to new research being ...
- Weight loss drugs helped drive 13.5% increase in pharma costs: Study
Hospital pharmaceutical costs marginally decreased in 2023 because of the lessened need for COVID-19 drugs, but overall healthcare spending on drugs grew 13.5% — largely because of weight loss ...
Go deeper with Google Headlines on:
COVID-19 drugs
[google_news title=”” keyword=”COVID-19 drugs” num_posts=”5″ blurb_length=”0″ show_thumb=”left”]
Go deeper with Bing News on:
Molecular docking
- Rakovina Therapeutics Inc. Announces 2023 Financial Results and Provides Corporate Update
VANCOUVER, British Columbia, April 26, 2024 (GLOBE NEWSWIRE) -- . (TSX-V: RKV, the “Company”) a biopharmaceutical company committed to advancing new cancer therapies based on novel DNA-damage response ...
- Researchers decipher how an enzyme modifies the genetic material in the cell nucleus
Inside the cell nucleus, the DNA molecule is found in a densely packed DNA-protein complex known as chromatin. Here the DNA is wrapped around a core of histone proteins and densely packed to form ...
- 4th LD-Writethru-Xinhua Headlines: Shenzhou-18 taikonauts start journey to space station for more sci-tech experiments
While in orbit, the Shenzhou-18 spaceship is scheduled to make a fast, automated rendezvous and docking with the space station combination ... the crew will also conduct molecular research on the ...
- Update: Shenzhou-18 taikonauts start journey to space station for more sci-tech experiments
China on Thursday launched the Shenzhou-18 manned spaceship that will send three taikonauts to the orbiting Tiangong space station for a six-month mission. The spaceship, atop a Long March-2F carrier ...
- Generative AI for Healthcare: Xaira Therapeutics Launches with $1 Billion Funding
ARCH Venture Partners and Foresite Labs have invested $1 billion in AI-driven drug discovery firm Xaira Therapeutics, aiming to revolutionize therapeutic product development by leveraging design ...
Go deeper with Google Headlines on:
Molecular docking
[google_news title=”” keyword=”molecular docking” num_posts=”5″ blurb_length=”0″ show_thumb=”left”]